$Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation$

Treating relapsed/refractory acute myeloid leukemia with chidamide, fludarabine, cytarabine and granulocyte-colony stimulating factor with subsequent bridging to myeloablative allogeneic hematopoietic stem cell transplantation

Saved in:

Bibliographic Details
Main Authors:	Wen Yao, Xinchen Fang, Peng Jiang, Juan Tong, Liangquan Geng, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Kaidi Song, Lei Zhang, Ping Qiang, Guangyu Sun, Yongsheng Han, Huilan Liu, Zimin Sun
Format:	Article
Language:	English
Published:	PAGEPress Publications 2022-02-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Online Access:	http://mjhid.org/index.php/mjhid/article/view/4856
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Prospective phase II study of allogeneic hematopoietic stem cell transplantation with targeted busulfan, fludarabine, and etoposide conditioning in pediatric acute lymphoblastic leukemia
by: Kyung Taek Hong, et al.
Published: (2024-12-01)

DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION
by: xinchen fang, et al.
Published: (2021-01-01)

The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients
by: Kristin J. Skaarud, et al.
Published: (2025-01-01)

The impact of granulocyte colony-stimulating factor and decitabine-containing conditioning in myelodysplastic syndrome patients with iron overload undergoing allogeneic hematopoietic stem cell transplantation: a retrospective study
by: Wenshu Zhao, et al.
Published: (2024-11-01)

Impact of Granulocyte Colony-Stimulating Factor (G-CSF) on Clinical Outcomes in Allogeneic Hematopoietic Cell Transplantation: Does Speeding Up Neutrophil Engraftment Make a Difference?
by: Ahmed Alnughmush, MD, et al.
Published: (2025-02-01)

The efficacy of Fludarabine, high dose cytosine arabinoside with granulocyte colony stimulating factor (FLAG) protocol as salvage therapy for Refractory/Relapsed Acute Leukemias in adult Iraqi patients.
by: Alaa Fadhil Alwan, et al.
Published: (2014-08-01)

Endocrinopathies after Allogeneic and Autologous Transplantation of Hematopoietic Stem Cells
by: Francesco Orio, et al.
Published: (2014-01-01)

Limbic Encephalitis following Allogeneic Hematopoietic Stem Cell Transplantation
by: Silje Johansen, et al.
Published: (2022-01-01)

Lower Number of Fludarabine Cycles in Patients with Lymphoid Malignancies
by: Donald Pasquale
Published: (2014-08-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ADULT PATIENTS WITH FANCONI ANEMIA.
by: hosein kamranzadeh fumani, et al.
Published: (2016-11-01)

ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: Mohamed L. Sorror, et al.
Published: (2010-06-01)

Management of Adenovirus in Children after Allogeneic Hematopoietic Stem Cell Transplantation
by: Winnie WY Ip, et al.
Published: (2013-01-01)

ROLE OF COMORBIDITIES IN OPTIMIZING DECISION-MAKING FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
by: Mohamed L. Sorror, et al.
Published: (2010-05-01)

Total body irradiation-based myeloablative conditioning for acute lymphoblastic leukaemia patients undergoing allogeneic haematopoietic stem cell transplantation: the best way to prevent relapse in a real-world scenario
by: Mario Delia, et al.
Published: (2025-01-01)

ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION IN THE TREATMENT OF CHRONIC LYMPHOCITIC LEUKEMIA : WHY AND WHEN ?
by: Maria L. Delioukina, et al.
Published: (2010-06-01)

Post-transplant cyclophosphamide or cell selection in haploidentical allogeneic hematopoietic cell transplantation?
by: Razan Mohty, et al.
Published: (2024-12-01)

Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation
by: Mary Nauffal, et al.
Published: (2024-01-01)

UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
by: José Luis Piñana, et al.
Published: (2024-08-01)

Advances in allogeneic hematopoietic stem cell transplantation for Langerhans cell histiocytosis in children
by: Guangqiang Meng, et al.
Published: (2025-01-01)

Reconstructing skeletal homeostasis through allogeneic hematopoietic stem cell transplantation in myelofibrosis
by: Mathias Schäfersküpper, et al.
Published: (2025-01-01)

The influence of immune checkpoint blockade on the outcomes of allogeneic hematopoietic stem cell transplantation
by: Yalei Hu, et al.
Published: (2024-11-01)

Purine metabolites regulate leukemic cell sensitivity toward cytarabine
by: Xiaowen Zhang, et al.
Published: (2025-01-01)

Case report: Dysphonia associated with high-dose cytarabine therapy
by: Ling Ma, et al.
Published: (2025-01-01)

Granulocytic Sarcoma by AML M4eo (inv16) after Allogeneic Stem Cell Transplantation without Bone Marrow Involvement
by: Stephan Zaenker, et al.
Published: (2011-01-01)

ROLE OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN ADULT PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
by: Federico Lussana, et al.
Published: (2014-10-01)

Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
by: Szymon Skoczen, et al.
Published: (2016-01-01)

VZV Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation in Children: When to Stop?
by: Eva deBerranger, et al.
Published: (2024-11-01)

Chidamide Suppresses the Growth of Cholangiocarcinoma by Inhibiting HDAC3 and Promoting FOXO1 Acetylation
by: Yongpan Li, et al.
Published: (2022-01-01)

A Clinical audit: Prophylactic granulocyte transfusion to prevent severe febrile neutropenia and subsequent infections in paediatric high-risk patients with leukemia
by: Aswathi Gangadharan, et al.
Published: (2024-01-01)

Recurrent Acute Pulmonary Toxicity and Respiratory Failure Associated with Fludarabine Monophosphate
by: Corey Cutler, et al.
Published: (1997-01-01)

The Value of Immature Granulocyte and Immature Granulocyte/Total Granulocyte Ratio in Predicting the Need for Surgical Treatment in Patients Diagnosed with Intestinal Ileus in the Emergency Department
by: Yunsur Çevik, et al.
Published: (2023-08-01)

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR ACUTE MYELOID LEUKEMIA OF THE ELDERLY: REVIEW OF THE LITERATURE AND PERSPECTIVES.
by: Gabriele Magliano, et al.
Published: (2020-10-01)

Methotrexate for the Treatment of Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation
by: Amr Nassar, et al.
Published: (2014-01-01)

Histoplasma capsulatum Infection in an Allogeneic Hematopoietic Stem Cell Transplant Patient Receiving Voriconazole Prophylaxis
by: Vaibhav Agrawal, et al.
Published: (2020-01-01)

Secondary cytopenia post allogeneic hematopoietic stem cell transplant in children: Risk factors and outcomes
by: Asmita Gawde, et al.
Published: (2024-01-01)

A retrospective study of an irradiation-based conditioning regimen and chidamide maintenance therapy in T-ALL/LBL
by: Xueying Wang, et al.
Published: (2024-12-01)

Fludarabine Treatment of Patient with Chronic Lymphocytic Leukemia Induces a Digital Ischemia
by: Utku Erdem Soyaltin, et al.
Published: (2016-01-01)

In Situ Evaluation of Fludarabine-DNA Interaction Using a DNA-Electrochemical Biosensor
by: H. Eda Satana, et al.
Published: (2011-01-01)

Influence of ESBL colonization status on gut microbiota composition during allogenic hematopoietic stem cell transplantation
by: Silvia Corcione, et al.
Published: (2025-01-01)

Effect of the radioprotector chlorophyllin on graft versus leukemia response in experimental allogeneic hematopoietic stem cell transplantation
by: Saurabh Kumar Gupta, et al.
Published: (2025-03-01)